In conclusion, this study demonstrated an AI system’s value in assisting medical professionals provide a non-invasive and easy-to-use method to identify the expression status of common genes EGFR and PD-L1 through CT images, which may serve as a predictive biomarker for guiding the target therapy and immunotherapy in NSCLC patients. This evidence concerns the gene EGFR and non-small cell lung carcinoma.